跳至主要内容
临床试验/NCT00175617
NCT00175617已完成2 期

Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss

University of British Columbia2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2005年9月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
2
主要终点
hair density

研究概览

简要总结

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects must be premenopausal women older than 18 with female pattern hair loss.

排除标准

  • Androgen excess
  • Other scalp or hair disorders
  • Contraindications to spironolactone treatment, especially pregnancy, electrolyte imbalances, history of breast cancer, or intake of interfering drugs
  • Contraindications to minoxidil treatment, especially patients who are allergic to this treatment or have a history of low blood pressure or irregular heart beats

结局指标

主要结局

hair density

时间窗: after 3, 6 and 9 months

次要结局

  • percentage of subjects who experience side effects
  • subject assessment of treatment effect

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验